Semaglutide Treatment in Type 1 Diabetes

Clinical trial NCT06909006 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06909006
Sponsor: Nordsjaellands Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity in Diabetes Obesity/Therapy Type 1 Diabetes Mellitus (T1DM)Insulin Sensitivity/Resistance Semaglutide Lipidomics Metabolomics Weight Loss Glycemic Control for Diabetes Mellitus

Start date: 2025-10-01
Primary completion: 2028-06-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.